VSEE HEALTH, INC. Files 8-K for Accountant, Financials
Ticker: VSEEW · Form: 8-K · Filed: Oct 14, 2025 · CIK: 1864531
| Field | Detail |
|---|---|
| Company | Vsee Health, Inc. (VSEEW) |
| Form Type | 8-K |
| Filed Date | Oct 14, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.0001, $11.50 |
| Sentiment | neutral |
Sentiment: neutral
Topics: auditor-change, financial-statements
Related Tickers: VSEE
TL;DR
VSEE HEALTH, INC. updated its auditor and financials on 9/15/2025.
AI Summary
VSEE HEALTH, INC. filed an 8-K on October 14, 2025, reporting changes in its certifying accountant and financial statements as of September 15, 2025. The company, formerly known as DIGITAL HEALTH ACQUISITION CORP., is incorporated in Delaware and has its principal business address in Boca Raton, Florida.
Why It Matters
This filing indicates a change in the company's auditor and provides updated financial information, which is crucial for investors to assess the company's financial health and compliance.
Risk Assessment
Risk Level: low — This is a routine filing regarding changes in certifying accountant and financial statements, not indicating any immediate operational or financial distress.
Key Players & Entities
- VSEE HEALTH, INC. (company) — Registrant
- DIGITAL HEALTH ACQUISITION CORP. (company) — Former Company Name
- September 15, 2025 (date) — Date of earliest event reported
- October 14, 2025 (date) — Filing Date
- Delaware (jurisdiction) — State of Incorporation
- Boca Raton, Florida (location) — Business Address
FAQ
What is the primary purpose of this 8-K filing for VSEE HEALTH, INC.?
The primary purpose is to report changes in the registrant's certifying accountant and to file financial statements and exhibits as of September 15, 2025.
When was the earliest event reported in this filing?
The earliest event reported was on September 15, 2025.
What was VSEE HEALTH, INC.'s former company name?
VSEE HEALTH, INC.'s former company name was DIGITAL HEALTH ACQUISITION CORP.
In which state is VSEE HEALTH, INC. incorporated?
VSEE HEALTH, INC. is incorporated in Delaware.
What is the business address of VSEE HEALTH, INC.?
The business address of VSEE HEALTH, INC. is 980 N FEDERAL HWY, #304, BOCA RATON, FL 33432.
Filing Stats: 1,044 words · 4 min read · ~3 pages · Grade level 14.2 · Accepted 2025-10-14 08:10:07
Key Financial Figures
- $0.0001 — e on which registered Common Stock, $0.0001 par value per share VSEE The Nasdaq
- $11.50 — (1) share of common stock at a price of $11.50 per whole share VSEEW The Nasdaq St
Filing Documents
- vsee8k101225.htm (8-K) — 34KB
- vseeex16-1.htm (EX-16.1) — 3KB
- 0001185185-25-001434.txt ( ) — 246KB
- vsee-20250915.xsd (EX-101.SCH) — 4KB
- vsee-20250915_def.xml (EX-101.DEF) — 26KB
- vsee-20250915_lab.xml (EX-101.LAB) — 36KB
- vsee-20250915_pre.xml (EX-101.PRE) — 25KB
- vsee8k101225_htm.xml (XML) — 6KB
01 Changes in Registrant's Certifying
Item 4.01 Changes in Registrant's Certifying Accountant. Dismissal of Prior Independent Registered Public Accounting Firm On September 15, 2025, VSee Health Inc., a Delaware Corporation (the "Company"), and the Company's board of directors (the "Board") notified WithumSmith+Brown, PC ("Withum"), the Company's independent registered public accounting firm, of its decision to dismiss Withum as the Company's independent registered public accounting firm, effective immediately. Although their audit was not designed to identify or detect violations of law or fraud, Withum's dismissal was not a result of any violation of law or fraud of the Company identified during its audit procedures to date. Withum served as the Company's independent registered public accounting firm since 2024. The report of Withum on the consolidated financial and was not qualified or modified as to uncertainty, audit scope or accounting principles except for the inclusion of an explanatory paragraph regarding the substantial doubt about the Company's ability to continue as a going concern. Additionally, during the fiscal year ended December 31, 2024, as well as subsequent interim periods preceding Withum's dismissal, there were no "disagreements" (as that term is described in Item 304(a)(1)(iv) of Regulation S-K and related instructions) between the Company and Withum with respect to any matter relating to accounting principles or practices, financial statement disclosure or auditing scope or procedures which, if not resolved to the satisfaction of Withum, would have caused Withum to make reference to the subject matter of the disagreements in its reports on the Company's consolidated financial statement with respect to such period, and there were no "reportable events" (as that term is defined in Item 304(a)(1)(v) of Regulation S-K and the related instr
01. A copy of the letter from Withum dated October 13, 2025, is attached hereto as Exhibit 16.1
Item 4.01. A copy of the letter from Withum dated October 13, 2025, is attached hereto as Exhibit 16.1. Appointment of New Independent Registered Public Accountant On September 18, 2025, following a competitive review process conducted by the Audit Committee of the Board, the Audit Committee approved the engagement of WWC, P.C. ("WWC") effective immediately as the Company's new independent registered public accounting firm for the audit of the Company's financial March 31, 2025, June 30, 2025 and September 30, 2025. During the fiscal years ended December 31, 2023 and 2024, and the subsequent interim periods through the date of WWC's appointment, neither the Company nor anyone on its behalf has consulted with WWC regarding either (i) the application of accounting principles to a specified transaction, either completed or proposed; or the type of audit opinion that might be rendered on the Company's financial statements, and neither a written report was provided to the Company nor oral advice was provided that WWC concluded was an important factor considered by the Company in reaching a decision as to the accounting, auditing or financial reporting issue or (ii) any matter that was either the subject of disagreement (as that term is described in Item 304(a)(1)(iv) of Regulation S-K and related instructions) or a reportable event (as that term is defined in Item 304(a)(1)(v) of Regulation S-K and the related instructions).
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 16.1 Letter from WithumSmith+Brown, PC to the Securities and Exchange Commission, dated October 13, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized. Dated: October 13, 2025 VSEE HEALTH, INC. By: /s/ Imoigele Aisiku Name: Imoigele Aisiku Title: Co-Chief Executive Officer 2